Cardiac calsequestrin: The new kid on the block in arrhythmias: Molecular perspectives

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 10, 2009, Pages 1179-1185

  Chopra, Nagesh ^a   Knollmann, Björn C ^b  

^a Division of Cardiology

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Cardiac calsequestrin; Catecholaminergic polymorphic ventricular tachycardia; Excitation contraction coupling; Sarcoplasmic reticulum; Ventricular tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALSEQUESTRIN; FLECAINIDE; RYANODINE RECEPTOR 2;

AMINO ACID SUBSTITUTION; ARRHYTHMOGENESIS; CALCIUM TRANSPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DEFIBRILLATOR; DISEASE PREDISPOSITION; DRUG MECHANISM; ECHOCARDIOGRAPHY; EXCITATION CONTRACTION COUPLING; GANGLIONECTOMY; GENE MUTATION; HEART DISEASE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALSEQUESTRIN; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION;

EID: 70350488601     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01531.x     Document Type: Review

References (62)

1. Fitzgerald GR, Cumming WJ, Scott DJ, Reid DS, Hunter AS : Localized left ventricular myocardial defect leading to fatal cerebral embolism. Br Heart J 1975 37 : 886 889.
2. Coumel P, Fidelle J, Lucet V : Catecholamine-induced severe ventricular arrhythmias with Adams Stokes syndrome in children: Report of four cases. Br Heart J 1978 40 (Suppl 28 37.
3. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P : Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995 91 : 1512 1519.
4. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA : Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001 103 : 196 200. (Pubitemid 32095402)
5. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A : Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002 106 : 69 74.
6. Swan H, Laitinen P, Kontula K, Toivonen L : Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol 2005 16 : 162 166.
7. Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S : Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007 4 : 1149 1154.
8. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K : Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001 103 : 485 490. (Pubitemid 32116230)
9. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M : A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001 69 : 1378 1384.
10. Postma AV, Denjoy I, Hoorntje TM, Lupoglazoff JM, Da Costa A, Sebillon P, Mannens MM, Wilde AA, Guicheney P : Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002 91 : e21 26.
11. Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG : Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: Insights from a RyR2 R4496C knock-in mouse model. Circ Res 2006 99 : 292 298.
12. Cerrone M, Colombi B, Santoro M, di Barletta MR, Scelsi M, Villani L, Napolitano C, Priori SG : Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 2005 96 : e77 82.
13. Knollmann BC, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K, Knollmann BE, Horton KD, Weissman NJ, Holinstat I, Zhang W, Roden DM, Jones LR, Franzini-Armstrong C, Pfeifer K : Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006 116 : 2510 2520.
14. Mohamed U, Napolitano C, Priori SG : Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2007 18 : 791 797. (Pubitemid 46934514)
15. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR : Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997 272 : 23389 23397.
16. Wang S, Trumble WR, Liao H, Wesson CR, Dunker AK, Kang CH : Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 1998 5 : 476 483.
17. Beard NA, Laver DR, Dulhunty AF : Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 2004 85 : 33 69.
18. Gyorke I, Hester N, Jones LR, Gyorke S : The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004 86 : 2121 2128.
19. Stern MD, Cheng H : Putting out the fire: What terminates calcium-induced calcium release in cardiac muscle? Cell Calcium 2004 35 : 591 601.
20. Terentyev D, Viatchenko-Karpinski S, Valdivia HH, Escobar AL, Gyorke S : Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes. Circ Res 2002 91 : 414 420.
21. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Volpe P, Williams SC, Gyorke S : Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A 2003 100 : 11759 11764.
22. Szentesi P, Pignier C, Egger M, Kranias EG, Niggli E : Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle. Circ Res 2004 95 : 807 813.
23. Chopra N, Kannankeril PJ, Yang T, Hlaing T, Holinstat I, Ettensohn K, Pfeifer K, Akin B, Jones LR, Franzini-Armstrong C, Knollmann BC : Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice. Circ Res 2007 101 : 617 626.
24. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, Lorber A, Kastner DL, Goldman B, Pras E : Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: Clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001 103 : 2822 2827.
25. Katz G, Arad M, Eldar M : Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Curr Probl Cardiol 2009 34 : 9 43.
26. Kim E, Youn B, Kemper L, Campbell C, Milting H, Varsanyi M, Kang C : Characterization of human cardiac calsequestrin and its deleterious mutants. J Mol Biol 2007 373 : 1047 1057.
27. Houle TD, Ram ML, Cala SE : Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium. Cardiovasc Res 2004 64 : 227 233.
28. Terentyev D, Nori A, Santoro M, Viatchenko-Karpinski S, Kubalova Z, Gyorke I, Terentyeva R, Vedamoorthyrao S, Blom NA, Valle G, Napolitano C, Williams SC, Volpe P, Priori SG, Gyorke S : Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 2006 98 : 1151 1158.
29. Qin J, Valle G, Nani A, Nori A, Rizzi N, Priori SG, Volpe P, Fill M : Luminal Ca2+ regulation of single cardiac ryanodine receptors: Insights provided by calsequestrin and its mutants. J Gen Physiol 2008 131 : 325 334.
30. Terentyev D, Kubalova Z, Valle G, Nori A, Vedamoorthyrao S, Terentyeva R, Viatchenko-Karpinski S, Bers DM, Williams SC, Volpe P, Gyorke S : Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: Effects of CASQ2 mutations linked to sudden cardiac death. Biophys J 2008 95 : 2037 2048.
31. Valle G, Galla D, Nori A, Priori SG, Gyorke S, de Filippis V, Volpe P : Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin. Biochem J 2008 413 : 291 303.
32. di Barletta MR, Viatchenko-Karpinski S, Nori A, Memmi M, Terentyev D, Turcato F, Valle G, Rizzi N, Napolitano C, Gyorke S, Volpe P, Priori SG : Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006 114 : 1012 1019.
33. Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, Terentyev D, Zhou Z, Vedamoorthyrao S, Li N, Chiamvimonvat N, Carnes CA, Franzini-Armstrong C, Gyorke S, Periasamy M : A mutation in calsequestrin, CASQ2D307H, impairs sarcoplasmic reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res 2007 75 : 69 78.
34. Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, Berul CI, Eldar M, Seidman CE, Seidman JG : Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2007 117 : 1814 1823.
35. Rizzi N, Liu N, Napolitano C, Nori A, Turcato F, Colombi B, Bicciato S, Arcelli D, Spedito A, Scelsi M, Villani L, Esposito G, Boncompagni S, Protasi F, Volpe P, Priori SG : Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: A complex arrhythmogenic cascade in a knock in mouse model. Circ Res 2008 103 : 298 306.
36. Jones LR, Suzuki YJ, Wang W, Kobayashi YM, Ramesh V, Franzini-Armstrong C, Cleemann L, Morad M : Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 1998 101 : 1385 1393.
37. Takahashi T, Allen PD, Lacro RV, Marks AR, Dennis AR, Schoen FJ, Grossman W, Marsh JD, Izumo S : Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 1992 90 : 927 935.
38. Munch G, Bolck B, Hoischen S, Brixius K, Bloch W, Reuter H, Schwinger RH : Unchanged protein expression of sarcoplasmic reticulum Ca2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium. J Mol Med 1998 76 : 434 441.
39. Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C : Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. J Med Genet 2005 42 : e59.
40. Chiu C, Tebo M, Ingles J, Yeates L, Arthur JW, Lind JM, Semsarian C : Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2007 43 : 337 343.
41. Kiarash A, Kelly CE, Phinney BS, Valdivia HH, Abrams J, Cala SE : Defective glycosylation of calsequestrin in heart failure. Cardiovasc Res 2004 63 : 264 272.
42. Kasneci A, Kemeny-Suss NM, Komarova SV, Chalifour LE : Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc Res 2009 81 : 695 702.
43. Khachigian LM : Early growth response-1 in cardiovascular pathobiology. Circ Res 2006 98 : 186 191.
44. Lohan J, Ohlendieck K : Drastic reduction in the luminal Ca2+ -binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. Biochim Biophys Acta 2004 1689 : 252 258.
45. Chu V, Otero JM, Lopez O, Sullivan MF, Morgan JP, Amende I, Hampton TG : Electrocardiographic findings in mdx mice: A cardiac phenotype of Duchenne muscular dystrophy. Muscle Nerve 2002 26 : 513 519.
46. Werdich AA, Baudenbacher F, Dzhura I, Jeyakumar LH, Kannankeril PJ, Fleischer S, LeGrone A, Milatovic D, Aschner M, Strauss AW, Anderson ME, Exil VJ : Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol 2007 292 : H2202 2211.
47. Tavi P, Sjogren M, Lunde PK, Zhang SJ, Abbate F, Vennstrom B, Westerblad H : Impaired Ca2+ handling and contraction in cardiomyocytes from mice with a dominant negative thyroid hormone receptor alpha1. J Mol Cell Cardiol 2005 38 : 655 663.
48. Park IY, Kim EJ, Park H, Fields K, Dunker AK, Kang C : Interaction between cardiac calsequestrin and drugs with known cardiotoxicity. Mol Pharmacol 2005 67 : 97 104.
49. Arai M, Tomaru K, Takizawa T, Sekiguchi K, Yokoyama T, Suzuki T, Nagai R : Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J Mol Cell Cardiol 1998 30 : 243 254.
50. Chopra N, Laver D, Davies SS, Knollmann BC : Amitriptyline activates cardiac ryanodine channels and causes spontaneous sarcoplasmic reticulum calcium release. Mol Pharmacol 2009 75 : 183 195.
51. Zima AV, Qin J, Fill M, Blatter LA : Tricyclic antidepressant amitriptyline alters sarcoplasmic reticulum calcium handling in ventricular myocytes. Am J Physiol Heart Circ Physiol 2008 295 : H2008 2016.
52. Ray WA, Meredith S, Thapa PB, Hall K, Murray KT : Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004 75 : 234 241. (Pubitemid 38314873)
53. Roden DM : Cellular basis of drug-induced torsades de pointes. Br J Pharmacol 2008 154 : 1502 1507.
54. Napolitano C, Priori SG : Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007 4 : 675 678. (Pubitemid 46655581)
55. Yuan Q, Fan GC, Dong M, Altschafl B, Diwan A, Ren X, Hahn HH, Zhao W, Waggoner JR, Jones LR, Jones WK, Bers DM, Dorn GW IInd., Wang HS, Valdivia HH, Chu G, Kranias EG : Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity. Circulation 2007 115 : 300 309.
56. Shen X, Franzini-Armstrong C, Lopez JR, Jones LR, Kobayashi YM, Wang Y, Kerrick WG, Caswell AH, Potter JD, Miller T, Allen PD, Perez CF : Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle. J Biol Chem 2007 282 : 37864 37874.
57. 2+ overload and ventricular arrhythmias in mice. Proc Natl Acad Sci U S A 2009 106 : 7636 7641.
58. Bhuiyan ZA, Hamdan MA, Shamsi ET, Postma AV, Mannens MM, Wilde AA, Al-Gazali L : A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiovasc Electrophysiol 2007 18 : 1060 1066.
59. Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ : Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008 358 : 2024 2029.
60. Yano M : Ryanodine receptor as a new therapeutic target of heart failure and lethal arrhythmia. Circ J 2008 72 : 509 514.
61. Venetucci LA, Trafford AW, O'Neill SC, Eisner DA : The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 2008 77 : 285 292.
62. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AA, Knollmann BC : Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009 15 : 380 383.